Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03043794 · ClinicalTrials.gov registry record · Phase 2
Study of Stereotactic Radiotherapy for Breast Cancer
A Phase 2 study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Terminated
- Registry status
- Phase 2
- Development phase
- 4
- Enrollment target
NCT03043794: Clinical Trial Phase 2 study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
NCT03043794 is a Phase 2 study that was terminated before completion, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 4 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03043794, a Phase 2 study, was terminated before completion, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 4 participants
- Enrollment target
Study Summary
This is a Phase II trial of preoperative stereotactic radiation to the breast for low risk breast cancer.
Primary Outcome
Number of participants with Residual Cancer Burden (RCB) designation 0 (also known as pathologic complete response (pCR)), and RCB I designation (combined endpoint of either of those designations) 4-6 weeks after pre-operative SBRT to intact breast tumors.
Interventions
- RADIATION Stereotactic Body Radiation Therapy SBRT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2023-10-22 |
| Phase | Phase 2 |
Why NCT03043794 stopped before completion
NCT03043794 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Stereotactic Body Radiation Therapy SBRT is the first listed.
NCT03043794 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03043794 about?
NCT03043794 is a clinical study titled "Study of Stereotactic Radiotherapy for Breast Cancer". This is a Phase II trial of preoperative stereotactic radiation to the breast for low risk breast cancer.
What is the current status of trial NCT03043794?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 4 participants. The study started on 2017-08-01. Estimated completion is 2023-10-22.
What interventions are being tested in trial NCT03043794?
The interventions under investigation include: Stereotactic Body Radiation Therapy SBRT (RADIATION).
Who is sponsoring clinical trial NCT03043794?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03043794's enrollment target sits among peer trials
4 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI